scispace - formally typeset
L

Luregn J. Schlapbach

Researcher at University of Queensland

Publications -  240
Citations -  6729

Luregn J. Schlapbach is an academic researcher from University of Queensland. The author has contributed to research in topics: Medicine & Sepsis. The author has an hindex of 35, co-authored 178 publications receiving 4164 citations. Previous affiliations of Luregn J. Schlapbach include University of Bern & Royal Children's Hospital.

Papers
More filters
Journal ArticleDOI

The global burden of paediatric and neonatal sepsis: a systematic review.

TL;DR: It is confirmed that sepsis is a common and frequently fatal condition affecting neonates and children globally, and few population-based data are available from low-income settings and the lack of standardisation of diagnostic criteria and definition of sepsi in the reviewed studies are obstacles to the accurate estimation of global burden.
Journal ArticleDOI

Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children

Scott L. Weiss, +53 more
TL;DR: A large cohort of international experts was able to achieve consensus regarding many recommendations for the best care of children with sepsis, acknowledging that most aspects of care had relatively low quality of evidence resulting in the frequent issuance of weak recommendations.
Journal ArticleDOI

Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children

Scott L. Weiss, +54 more
TL;DR: A large cohort of international experts was able to achieve consensus regarding many recommendations for the best care of children with sepsis, acknowledging that most aspects of care had relatively low quality of evidence resulting in the frequent issuance of weak recommendations.
Journal ArticleDOI

Impact of Sepsis on Neurodevelopmental Outcome in a Swiss National Cohort of Extremely Premature Infants

TL;DR: Proven sepsis significantly contributes to NDI in extremely preterm infants, independent of other risk factors, and better strategies aimed at reducing the incidence of Sepsis in this highly vulnerable population are needed.
Journal ArticleDOI

A Randomized Trial of High-Flow Oxygen Therapy in Infants with Bronchiolitis

TL;DR: Among infants with bronchiolitis who were treated outside an ICU, those who received high‐flow oxygen therapy had significantly lower rates of escalation of care due to treatment failure than those in the group that received standard oxygen therapy.